Drug-induced hypothyroidism in tuberculosis.
Juan Eduardo Quiroz-AldaveMaría Del Carmen Durand-VásquezElman Rolando Gamarra-OsorioLuis Alberto Concepción UrteagaSamuel Pecho-SilvaLuis Alejandro Rodriguez-HidalgoMarcio José Concepción-ZavaletaPublished in: Expert review of endocrinology & metabolism (2024)
Antitubercular drug-induced hypothyroidism is more common than previously thought, affecting one in six MDR-TB patients. Despite diagnostic and treatment recommendations, implementation is hindered in low-income countries due to the lack of certified laboratories. New drugs for tuberculosis treatment may affect thyroid function, requiring vigilant monitoring for complications, including hypothyroidism.
Keyphrases
- drug induced
- liver injury
- mycobacterium tuberculosis
- replacement therapy
- adverse drug
- end stage renal disease
- primary care
- healthcare
- ejection fraction
- chronic kidney disease
- newly diagnosed
- hiv aids
- combination therapy
- prognostic factors
- pulmonary tuberculosis
- quality improvement
- human immunodeficiency virus
- antiretroviral therapy